News: Investments in Canadian Securities – Formation Biologics Inc., Oryx Petroleum

Company Name: Formation Biologics Inc.
Head Office: Montreal, Quebec, Canada
Number of Employees: 1 to 49
Total Assets: Under $5 million

August 16, 2019 – Formation Biologics Inc. sold 1,025 convertible Class C Preference Shares at a price of $90 per share for $92,250.

Each Preference Shares has a conversion ratio of 1:1 to Common.

The securities were sold to 2 accredited investors in Switzerland.

Formation Biologics Inc. is a clinical-stage protein engineering company that designs and develops biotherapeutics for the treatment of cancer and fibrotic diseases. Forbius was founded in 2011 as a management-led spin out from YM BioSciences, prior to YM’s acquisition by Gilead.


Company Name: Oryx Petroleum Corporation Ltd.
Head Office: Calgary, Alberta, Canada
Number of Employees: 100 to 499
Total Assets: $500 million to $1 billion

August 19, 2019 – Oryx Petroleum sold 23,901,430 Common Shares at a price of $0.2789 per unit for $6,666,109.

The securities were sold to 1 accredited investor in Netherlands.

Oryx Petroleum is an international oil exploration, development and production company focused in Africa and the Middle East.


This author writes about mergers & acquisitions and investments in Canadian businesses. For investors in Canada.